Molecular Forecaster Inc.
PrivateLast Round
Grant
Sep 28, 2021
Total Funding Raised
$787,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Molecular Forecaster Inc. operates in Healthcare & Life Sciences and is based in Montreal. Its latest recorded funding round was a Grant round in September 2021.
Molecular Forecaster Inc. is a computational chemistry company that provides research-as-a-service (RaaS) and proprietary software for small molecule drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Molecular Forecaster Inc. Comparables
Compare Molecular Forecaster Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioSolveIT | 87% | |
| Molsoft LLC | 86% | |
| Chemical Computing Group | 84% |
For institutional investors. Book with your work email.
Molecular Forecaster Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Molecular Forecaster Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investissement Québec | Grant |
| Génome Québec | Grant |
| Consortium Québécois sur la découverte du médicament | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 18, 2026
Grew 16% QoQ, from 19 to 22 employees.
- Jul 27, 2026
Grew 22% QoQ, from 18 to 22 employees.
For institutional investors. Book with your work email.
Molecular Forecaster Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Molecular Forecaster Inc.'s valuation, stock price, and market status.
Is Molecular Forecaster Inc. a public or private company?
Molecular Forecaster Inc. is a private company.
What is the current stock price of Molecular Forecaster Inc.?
Molecular Forecaster Inc. is a private company, so its shares have no public market price. Caplight tracks Molecular Forecaster Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Molecular Forecaster Inc. worth (valuation)?
Valuation information for Molecular Forecaster Inc. is not publicly available.
Can I buy Molecular Forecaster Inc. stock?
Molecular Forecaster Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Molecular Forecaster Inc.'s last funding round?
Molecular Forecaster Inc.'s most recent funding round was Grant on September 28, 2021.
Who are the main investors in Molecular Forecaster Inc.?
Key investors in Molecular Forecaster Inc. include Investissement Québec, Génome Québec, Consortium Québécois sur la découverte du médicament.
Will Molecular Forecaster Inc. IPO soon?
No public IPO plans have been announced for Molecular Forecaster Inc..
How can I track Molecular Forecaster Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Molecular Forecaster Inc.'s shares on secondary markets.